Photocure ASA

Regulatory Filings • Mar 28, 2019

Patients want Blue Light Cystoscopy

Patients want Blue Light Cystoscopy

A large survey posted by the Bladder Cancer Advocacy Network (BCAN) and

published in UroToday revealed a growing preference for Cysview®.

A survey of 600 bladder cancer patients posted by the Bladder Cancer Advocacy

Network (BCAN) in January revealed a growing preference for Blue Light

Cystoscopy with Cysview. Of the respondents, 438 reported having received

Cysview and said they were diagnosed at one facility, but then went to another

that offers Blue Light Cystoscopy (BLCT) with Cysview.

Read more on UroToday (https://www.urotoday.com/recent-abstracts/urologic

-oncology/bladder-cancer/111331-survey-of-bladder-cancer-patients-reveals-big

-changes-patients-are-looking-for-cysview-hexaminolevulinate.html)